Although selective inhibitors of MAO-B are clinically use for the treatment of neurological disorders such as Parkinson’s disease and Alzheimer’s disease, the isoenzyme MAO-A inhibitors are currently in use for the treatment of depression42. Here, MAOB is linked to early-onset autosomal dominant Alzheimer disease.